• Profile
Close

Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals: A randomised controlled trial

Metabolism Jan 17, 2018

Ferguson JJA, et al. - Herein, experts probed into the effects of dietary intervention with phytosterols (PS) with or without curcumin on blood lipids (primary outcome) in hypercholesterolaemic subjects. Findings disclosed that curcumin plus phytosterol therapy imparted a complementary cholesterol-lowering effect, larger than phytosterol therapy alone. This data aided in the formulation of a single functional food containing both the active ingredients for enhanced lipid-lowering and compliance in such individuals.

Methods

  • Hypercholesterolaemic particpants were analyzed during this double-blinded, randomised, placebo-controlled, 2 × 2 factorial trial.
  • Candidates received either placebo (PL, no phytosterols or curcumin), phytosterols (PS, 2 g/d), curcumin (CC, 200 mg/d) or a combination of PS and curcumin (PS-CC, 2 g/d-200 mg/d respectively) for four weeks.
  • Fasting total cholesterol (TC), LDL-cholesterol, HDL-cholesterol, triglycerides (TG), TC-to-HDL-C ratio (TC:HDL-C) were included as the primary outcomes.
  • Anthropometrics and fasting blood glucose concentrations served as the secondary outcomes.

Results

  • This research was completed by 70 subjects, with a mean (±SEM) fasting TC concentration of 6.57 ± 0.13 mmol/L (PL, n = 18; PS, n = 17; CC, n = 18; PS-CC, n = 17).
  • A prominent lowering of TC, LDL-cholesterol and TC:HDL-C post-intervention (p < 0.05) was achieved by PS and PS-CC supplementation.
  • It was determined that the reductions from baseline in the PS group were 4.8% and 8.1% for TC and LDL-cholesterol respectively (p < 0.05).
  • Non-significant reduction (2.3% and 2.6%) was illustrated in TC and LDL-C respectively by CC.
  • Nevertheless, the PS-CC gave rise to a greater reduction in TC (11.0%) and LDL-cholesterol (14.4%) when compared to either of the treatments alone (p < 0.0001).
  • A substantially greater reduction was yielded in the PS-CC treatment compared to those for CC (p < 0.05) or PL (p < 0.01) alone.
  • Across all groups, plasma HDL-cholesterol and TG concentrations did not alter.
  • Findings did not disclose any adverse side effects.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay